NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis → Grab Your Free Bitcoin Today! (From Crypto Swap Profits) (Ad) Free LFST Stock Alerts $6.17 +0.15 (+2.49%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$5.98▼$6.3450-Day Range$5.64▼$8.7152-Week Range$4.74▼$9.59Volume1.37 million shsAverage Volume1.20 million shsMarket Capitalization$2.35 billionP/E RatioN/ADividend YieldN/APrice Target$8.60 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get LifeStance Health Group alerts: Email Address LifeStance Health Group MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside39.4% Upside$8.60 Price TargetShort InterestBearish24.66% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.44Based on 2 Articles This WeekInsider TradingSelling Shares$1.71 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.30) to ($0.23) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.95 out of 5 starsMedical Sector692nd out of 938 stocksHealth Services Industry8th out of 10 stocks 3.0 Analyst's Opinion Consensus RatingLifeStance Health Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.60, LifeStance Health Group has a forecasted upside of 39.4% from its current price of $6.17.Amount of Analyst CoverageLifeStance Health Group has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted24.66% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 15.5, which indicates bearish sentiment.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 23.45%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LFST. Previous Next 3.0 News and Social Media Coverage News SentimentLifeStance Health Group has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for LifeStance Health Group this week, compared to 2 articles on an average week.Search Interest4 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,709,985.00 in company stock.Percentage Held by InsidersOnly 8.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for LifeStance Health Group are expected to grow in the coming year, from ($0.30) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is -12.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is -12.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About LifeStance Health Group Stock (NASDAQ:LFST)LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Read More LFST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LFST Stock News HeadlinesMarch 19, 2024 | insidertrades.comKevin Michael Mullins Sells 44,540 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) StockMarch 13, 2024 | insidertrades.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Sells $96,992.28 in StockMarch 29, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.March 20, 2024 | investing.comLifeStance Health executive sells over $280k in company stockMarch 20, 2024 | markets.businessinsider.comLifeist Announces Results of Annual General and Special Meeting of ShareholdersMarch 19, 2024 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Insider Kevin Michael Mullins Sells 44,540 Shares of StockMarch 13, 2024 | investing.comLifestance Health Group Inc (LFST)March 12, 2024 | finance.yahoo.comLifeStance Appoints Dr. Teresa DeLuca to Board of DirectorsMarch 29, 2024 | Crypto Swap Profits (Ad)Grab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTMarch 2, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported And Analysts Have Been Lifting Their Price TargetsMarch 1, 2024 | seekingalpha.comLifeStance Health Group, Inc. (LFST) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | finance.yahoo.comLifeStance Health Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 1, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)February 29, 2024 | ca.finance.yahoo.comLFST Oct 2024 3.000 putFebruary 29, 2024 | markets.businessinsider.comBarclays Keeps Their Sell Rating on Lifestance Health Group (LFST)February 29, 2024 | finance.yahoo.comLifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | seekingalpha.comLifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is ProblematicFebruary 28, 2024 | msn.comWhy Is Behavioral Health-Focused LifeStance Health Stock Trading Higher Thursday?February 28, 2024 | finanznachrichten.deLifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2023 ResultsFebruary 28, 2024 | benzinga.comRecap: LifeStance Health Gr Q4 EarningsFebruary 28, 2024 | marketwatch.comLifeStance Shares Jump on Strong 4QFebruary 28, 2024 | finance.yahoo.comLifeStance Health Group Inc Reports Growth Amidst Challenges in Q4 and Full Year 2023 ResultsFebruary 28, 2024 | globenewswire.comLifeStance Reports Fourth Quarter and Full Year 2023 ResultsFebruary 24, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFSTFebruary 22, 2024 | investorplace.comRed Flag Alert: 3 Stocks That Hindenburg Research Is Shorting NowSee More Headlines Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today3/28/2024Next Earnings (Estimated)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:LFST CUSIPN/A CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees9,325Year FoundedN/APrice Target and Rating Average Stock Price Target$8.60 High Stock Price Target$9.00 Low Stock Price Target$8.00 Potential Upside/Downside+39.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-186,260,000.00 Net Margins-17.64% Pretax Margin-19.57% Return on Equity-12.66% Return on Assets-8.65% Debt Debt-to-Equity Ratio0.20 Current Ratio1.11 Quick Ratio1.11 Sales & Book Value Annual Sales$1.06 billion Price / Sales2.22 Cash FlowN/A Price / Cash FlowN/A Book Value$3.77 per share Price / Book1.64Miscellaneous Outstanding Shares380,690,000Free Float348,331,000Market Cap$2.35 billion OptionableOptionable Beta1.41 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Kenneth Alan Burdick (Age 65)CEO & Chairman Comp: $624.22kMr. Danish J. Qureshi (Age 39)President & COO Comp: $342.2kMr. David Patrick Bourdon (Age 54)Chief Financial Officer & Treasurer Comp: $368.6kMs. Monica ProkockiVice President of Investor RelationsMr. Ryan Pardo (Age 48)Chief Legal Officer & Secretary Brooke MatthewsDirector of Public RelationsMs. Ann Varanakis (Age 46)Chief People Officer Mr. Pablo Pantaleoni (Age 36)Chief Digital Officer Mr. Kevin Michael Mullins (Age 39)Chief Development Officer Ms. Paula WoodChief Business Transformation OfficerMore ExecutivesKey CompetitorsPrivia Health GroupNASDAQ:PRVAMagellan HealthNASDAQ:MGLNPremierNASDAQ:PINCU.S. Physical TherapyNYSE:USPH1Life HealthcareNASDAQ:ONEMView All CompetitorsInsiders & InstitutionsKevin Michael MullinsSold 44,540 sharesTotal: $281,938.20 ($6.33/share)Vanguard Group Inc.Bought 48,574 shares on 3/11/2024Ownership: 1.989%David BourdonSold 58,826 sharesTotal: $407,664.18 ($6.93/share)Paula CipolloneSold 13,996 sharesTotal: $96,992.28 ($6.93/share)Kevin Michael MullinsSold 115,136 sharesTotal: $923,390.72 ($8.02/share)View All Insider TransactionsView All Institutional Transactions LFST Stock Analysis - Frequently Asked Questions Should I buy or sell LifeStance Health Group stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LifeStance Health Group in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" LFST shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LFST, but not buy additional shares or sell existing shares. View LFST analyst ratings or view top-rated stocks. What is LifeStance Health Group's stock price target for 2024? 5 brokerages have issued 12 month price objectives for LifeStance Health Group's shares. Their LFST share price targets range from $8.00 to $9.00. On average, they anticipate the company's stock price to reach $8.60 in the next year. This suggests a possible upside of 39.4% from the stock's current price. View analysts price targets for LFST or view top-rated stocks among Wall Street analysts. How have LFST shares performed in 2024? LifeStance Health Group's stock was trading at $7.83 at the beginning of the year. Since then, LFST stock has decreased by 21.2% and is now trading at $6.17. View the best growth stocks for 2024 here. Are investors shorting LifeStance Health Group? LifeStance Health Group saw a drop in short interest in March. As of March 15th, there was short interest totaling 20,790,000 shares, a drop of 23.5% from the February 29th total of 27,160,000 shares. Based on an average daily trading volume, of 1,340,000 shares, the days-to-cover ratio is presently 15.5 days. Currently, 24.7% of the shares of the company are sold short. View LifeStance Health Group's Short Interest. When is LifeStance Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our LFST earnings forecast. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) announced its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. The firm had revenue of $280.60 million for the quarter, compared to analyst estimates of $263.14 million. LifeStance Health Group had a negative net margin of 17.64% and a negative trailing twelve-month return on equity of 12.66%. What ETFs hold LifeStance Health Group's stock? ETFs with the largest weight of LifeStance Health Group (NASDAQ:LFST) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), Global X Telemedicine & Digital Health ETF (EDOC) and First Trust Small Cap Growth AlphaDEX Fund (FYC).iShares U.S. Healthcare Providers ETF (IHF) and What guidance has LifeStance Health Group issued on next quarter's earnings? LifeStance Health Group updated its first quarter 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $287.0 million-$307.0 million, compared to the consensus revenue estimate of $299.1 million. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.00%), Vanguard Group Inc. (1.99%), Brown Advisory Inc. (1.36%), Principal Financial Group Inc. (1.06%), Jennison Associates LLC (0.51%) and Northern Trust Corp (0.33%). Insiders that own company stock include Anisha Patel-Dunn, Ann Varanakis, Danish J Qureshi, David Bourdon, Gwen H Booth, Jeffrey Crisan, Jesse Michael Bruff, Kenneth T Mills, Kevin Michael Mullins, Michael K Lester, Paula Cipollone, Ryan Pardo, Silversmith Partners I Gp, Llc, Summit Partners Growth Equity and Warren Gouk. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:LFST) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.